From: Optimized sample preparation and data analysis for TMT proteomic analysis of cerebrospinal fluid applied to the identification of Alzheimer’s disease biomarkers
Amount TMT/50 µL CSF [mg]
Labeling efficiency [%]
Median peptide CV [%]
Median protein CV [%]
Median log2(MRII)
0.5
91.42
43.9
36.9
16.2
0.25
87.93
47.5
36.1
14.5
0.1
79.98
45.5
34.6
15.7